Lipid-modifying therapies face flat sales

被引：0
|
作者：
Bogdanovic, Sreten
机构：
来源：
GENETIC ENGINEERING & BIOTECHNOLOGY NEWS | 2008年 / 28卷 / 17期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：20 / 20
页数：1
相关论文
共 50 条
  • [31] Clinical trials of lipid-modifying agents: design considerations
    Bowman, Louise
    Haynes, Richard
    Armitage, Jane
    [J]. CLINICAL LIPIDOLOGY, 2011, 6 (01) : 109 - 116
  • [32] Effects of different lipid-modifying drugs an lipoprotein subclasses
    Segrest, JP
    Osterlund, LC
    Henkin, Y
    [J]. CIRCULATION, 1999, 100 (18) : 257 - 258
  • [33] Trends in lipid-modifying agent use in 83 countries
    Blais, Joseph E.
    Wei, Yue
    Yap, Kevin K. W.
    Alwafi, Hassan
    Ma, Tian-Tian
    Brauer, Ruth
    Lau, Wallis C. Y.
    Man, Kenneth K. C.
    Siu, Chung Wah
    Tan, Kathryn C. B.
    Wong, Ian C. K.
    Wei, Li
    Chan, Esther W.
    [J]. ATHEROSCLEROSIS, 2021, 328 : 44 - 51
  • [34] Use of Lipid-Modifying Agents for the Treatment of Glomerular Diseases
    Ge, Mengyuan
    Merscher, Sandra
    Fornoni, Alessia
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (08):
  • [35] CONTRIBUTION OF MULTIPLE COMPONENTS TO THE LIPID-MODIFYING EFFECTS OF XUEZHIKANG
    Duan, Z.
    Guo, S.
    Capuzzi, D.
    Li, S.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [36] Severe hypertriglyceridaemia in patients treated with lipid-modifying agents
    Desamericq, G.
    Van Ganse, E.
    Schwalm, M. -S.
    Bourke, A.
    Moulin, P.
    [J]. DIABETES & METABOLISM, 2012, 38 (03) : 277 - 279
  • [37] Trends in utilization of lipid-modifying drugs in European Countries
    Papaioannidou, P.
    Stergiopoulou, T.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (SUPPL 1) : S74 - S74
  • [38] Atorvastatin: An effective lipid-modifying agent in familial hypercholesterolemia
    Marais, AD
    Firth, JC
    Bateman, ME
    Byrnes, P
    Martens, C
    Mountney, J
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (08) : 1527 - 1531
  • [39] Attainment of Goal and Normalized Lipid Levels With Lipid-Modifying Therapy in Malaysia
    Hsu, Tun-Ying
    Chirovsky, Diana
    Moy, Foong Ming
    Ambegaonkar, Baishali M.
    [J]. CLINICAL THERAPEUTICS, 2013, 35 (04) : 450 - 460
  • [40] Comparing Medication Adherence Methods in Lipid-Modifying Therapy
    Lafleur, Joanne
    McAdam-Marx, Carrie
    White, George L.
    Lyon, Joseph L.
    Oderda, Gary M.
    [J]. JOURNAL OF PHARMACY TECHNOLOGY, 2012, 28 (02) : 58 - 67
12345